Nocturne provides products and services to improve the diagnostic and monitoring of neurologic disorders through imaging of the eye, based on state-of-the-art AI analysis. Currently, our main focus is multiple sclerosis, with future applications in Parkinson’s and Alzheimer’s disease. Our goal is to improve the accuracy of the initial diagnosis and to provide a close disease monitoring for initiating the right treatment and treatment adjustment, with the possibility of reducing the number of costly and time-consuming MRI examinations